Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.
暂无分享,去创建一个
Aviad Tsherniak | Gavin Ha | William C Hahn | Juliann Shih | Joshua D. Campbell | Matthew Meyerson | Francisca Vazquez | Ashton C. Berger | Galen F Gao | Andrew D Cherniack | Joshua D Campbell | W. Hahn | M. Meyerson | J. Francis | G. Ha | A. Cherniack | F. Vazquez | G. Gao | J. Shih | Aviad Tsherniak | Y. Mitsuishi | Alison M. Taylor | A. Ramachandran | Xiaoyang Zhang | M. Giannakis | Marios Giannakis | Joshua M Francis | Aruna Ramachandran | Ashton C Berger | Peter S Choi | Xiaoyang Zhang | Alison M Taylor | Yoichiro Mitsuishi | Jin Zhou | Zhong Wu | Jin Zhou | Zhong Wu | P. Choi | J. Campbell
[1] C. Teng,et al. Phosphorylation of Kruppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function. , 2003, Nucleic acids research.
[2] Yusuke Nakamura,et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer , 2014, Nature Genetics.
[3] Swneke D. Bailey,et al. Laying a solid foundation for Manhattan--'setting the functional basis for the post-GWAS era'. , 2014, Trends in genetics : TIG.
[4] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[5] Cheryl H. Arrowsmith,et al. Prevalent p53 mutants co-opt chromatin pathways to drive cancer growth , 2015, Nature.
[6] Swneke D. Bailey,et al. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus , 2012, Genome research.
[7] Timothy E. Reddy,et al. Highly Specific Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements , 2015, Nature Methods.
[8] V. Yang,et al. A Colon Cancer-derived Mutant of Krüppel-like Factor 5 (KLF5) Is Resistant to Degradation by Glycogen Synthase Kinase 3β (GSK3β) and the E3 Ubiquitin Ligase F-box and WD Repeat Domain-containing 7α (FBW7α)* , 2014, The Journal of Biological Chemistry.
[9] L. Mirny,et al. The 3D Genome as Moderator of Chromosomal Communication , 2016, Cell.
[10] K. Soo,et al. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity , 2016, Nature Communications.
[11] L. Jia,et al. KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2 , 2016, Oncogene.
[12] Chandra Sekhar Pedamallu,et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas , 2016, Nature Genetics.
[13] Jing Liang,et al. Chromatin architecture reorganization during stem cell differentiation , 2015, Nature.
[14] P. Leder,et al. The human c-myc oncogene: Structural consequences of translocation into the igh locus in Burkitt lymphoma , 1983, Cell.
[15] V. Chatterjee,et al. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia , 1998, Nature Genetics.
[16] Trevor J Pugh,et al. Landscape of genomic alterations in cervical carcinomas , 2013, Nature.
[17] P. Gregory,et al. Controlling Long-Range Genomic Interactions at a Native Locus by Targeted Tethering of a Looping Factor , 2012, Cell.
[18] Steven J. M. Jones,et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.
[19] J. Simons,et al. KLF5 promotes cell proliferation and tumorigenesis through gene regulationin the TSU‐Pr1 human bladder cancer cell line , 2006, International journal of cancer.
[20] Clifford A. Meyer,et al. Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.
[21] B. Clurman,et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[23] A. Services,et al. Integrated genomic and molecular characterization of cervical cancer. , 2017 .
[24] R. Blumenthal,et al. Structural basis for Klf4 recognition of methylated DNA , 2014, Nucleic acids research.
[25] A. Ferrando,et al. The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability , 2013, Cell.
[26] E. Lander,et al. Comprehensive assessment of cancer missense mutation clustering in protein structures , 2015, Proceedings of the National Academy of Sciences.
[27] Shuangxi Li,et al. The Fbw7/Human CDC4 Tumor Suppressor Targets Proproliferative Factor KLF5 for Ubiquitination and Degradation through Multiple Phosphodegron Motifs* , 2010, The Journal of Biological Chemistry.
[28] V. Yang,et al. Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. , 2008, Gastroenterology.
[29] Benjamin J. Raphael,et al. Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.
[30] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[31] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[32] Zhongmei Zhou,et al. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5 , 2015, Nature Communications.
[33] S. Elledge,et al. Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase , 2001, Science.
[34] J. M. Shields,et al. Identification and Characterization of a Gene Encoding a Gut-enriched Krüppel-like Factor Expressed during Growth Arrest* , 1996, The Journal of Biological Chemistry.
[35] A. Sivachenko,et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer , 2012, Nature Genetics.
[36] Ryan M. Layer,et al. LUMPY: a probabilistic framework for structural variant discovery , 2012, Genome Biology.
[37] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[38] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[39] G. Heinze,et al. Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer , 2006, Clinical Cancer Research.
[40] Marcin Imielinski,et al. Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers , 2015, Nature Genetics.
[41] David A. Orlando,et al. Mediator and Cohesin Connect Gene Expression and Chromatin Architecture , 2010, Nature.
[42] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[43] M. Crossley,et al. Mammalian Krüppel-like transcription factors: more than just a pretty finger. , 1999, Trends in biochemical sciences.
[44] Wen Tan,et al. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations , 2011, Nature Genetics.
[45] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[46] T. Golub,et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.
[47] T. Golub,et al. Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. , 2016, Cancer discovery.
[48] R. Young,et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.
[49] M. Rydzanicz,et al. Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors. , 2008, Neoplasma.
[50] Zhongmei Zhou,et al. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis. , 2012, Carcinogenesis.
[51] R. Young,et al. Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.
[52] Max A. Horlbeck,et al. Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.
[53] H. Aburatani,et al. CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5 , 2012, Proceedings of the National Academy of Sciences.
[54] Steven J. M. Jones,et al. Integrated genomic and molecular characterization of cervical cancer , 2017, Nature.
[55] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[56] Raffaele Pezzilli,et al. Common variation at 2 p 13 . 3 , 3 q 29 , 7 p 13 and 17 q 25 . 1 associated with susceptibility to pancreatic cancer , 2022 .
[57] A. Ferrando,et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia , 2007, The Journal of experimental medicine.
[58] Aaron R. Quinlan,et al. BIOINFORMATICS APPLICATIONS NOTE , 2022 .
[59] Daniel S. Day,et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods , 2015, Science.
[60] Kari Stefansson,et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations , 2009, Nature Genetics.
[61] Jesse R. Dixon,et al. Topological Domains in Mammalian Genomes Identified by Analysis of Chromatin Interactions , 2012, Nature.
[62] M. Freedman,et al. Chromosome 8q24-Associated Cancers and MYC. , 2010, Genes & cancer.
[63] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[64] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[65] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[66] Wei Zheng,et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.
[67] Hanfei Sun,et al. Target analysis by integration of transcriptome and ChIP-seq data with BETA , 2013, Nature Protocols.
[68] L. Hennighausen,et al. Hierarchy within the mammary STAT5-driven Wap super-enhancer , 2016, Nature Genetics.
[69] Mark W. Youngblood,et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas , 2016, Nature Genetics.
[70] M. Gurney,et al. The Notch Intracellular Domain Is Ubiquitinated and Negatively Regulated by the Mammalian Sel-10 Homolog* , 2001, The Journal of Biological Chemistry.
[71] Adam A. Margolin,et al. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity , 2012, Nature.
[72] Hui Zhao,et al. Five endometrial cancer risk loci identified through genome-wide association analysis , 2016, Nature Genetics.
[73] Takafumi N. Yamaguchi,et al. TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer , 2017, Nature Genetics.
[74] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[75] David A. Orlando,et al. Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.
[76] Teresa Palomero,et al. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia , 2014, Nature Medicine.
[77] Yusuke Nakamura,et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population , 2010, Nature Genetics.
[78] Pablo Tamayo,et al. ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens , 2013, Genome research.
[79] Shawn M. Gillespie,et al. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma , 2016, Nature Genetics.
[80] Nathan C. Sheffield,et al. The accessible chromatin landscape of the human genome , 2012, Nature.
[81] Rob Pieters,et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors , 2007, The Journal of experimental medicine.
[82] Swneke D. Bailey,et al. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression , 2012, Nature Genetics.
[83] H. Clevers,et al. KLF5 regulates the integrity and oncogenicity of intestinal stem cells. , 2014, Cancer research.
[84] R. Young,et al. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element , 2014, Science.
[85] Meagan E. Sullender,et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.
[86] H. Ng,et al. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development , 2014, Gut.
[87] S. Imai,et al. The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* , 2004, Journal of Biological Chemistry.
[88] Tsutomu Ohta,et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy , 2008, Proceedings of the National Academy of Sciences.
[89] Khay Guan Yeoh,et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets , 2012, Gut.
[90] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[91] J. Trent,et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.
[92] Mark D Robinson,et al. edgeR for differential RNA-seq and ChIP-seq analysis: an application to stem cell biology. , 2014, Methods in molecular biology.
[93] D. Coppola,et al. Nicotinamide phosphoribosyltransferase in malignancy: a review. , 2013, Genes & cancer.
[94] H. Wu,et al. NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response , 2011, Oncogene.
[95] J. Minna,et al. Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.
[96] Nicholas A. Sinnott-Armstrong,et al. Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer , 2016, Nature Genetics.
[97] Vincent W. Yang,et al. Intestinal-enriched Krüppel-like Factor (Krüppel-like Factor 5) Is a Positive Regulator of Cellular Proliferation* , 2001, The Journal of Biological Chemistry.
[98] M. Tyers,et al. Structural Basis for Phosphodependent Substrate Selection and Orientation by the SCFCdc4 Ubiquitin Ligase , 2003, Cell.
[99] Donna D. Zhang,et al. The emerging role of the Nrf2–Keap1 signaling pathway in cancer , 2013, Genes & development.
[100] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[101] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[102] M. Meyerson,et al. Copy number alterations unmasked as enhancer hijackers , 2016, Nature Genetics.
[103] Daniel S. Day,et al. Insulated Neighborhoods: Structural and Functional Units of Mammalian Gene Control , 2016, Cell.
[104] A. Visel,et al. ChIP-seq accurately predicts tissue-specific activity of enhancers , 2009, Nature.
[105] Liliana Goumnerova,et al. MYB-QKI rearrangements in Angiocentric Glioma drive tumorigenicity through a tripartite mechanism , 2016, Nature Genetics.
[106] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[107] Jaie C. Woodard,et al. Survey of variation in human transcription factors reveals prevalent DNA binding changes , 2016, Science.
[108] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[109] Ming Yu,et al. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation , 2013, Genes & development.
[110] Peng Guo,et al. Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription , 2015, Oncotarget.
[111] R. Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[112] Michael D. Cole,et al. Upregulation of c-MYC in cis through a Large Chromatin Loop Linked to a Cancer Risk-Associated Single-Nucleotide Polymorphism in Colorectal Cancer Cells , 2010, Molecular and Cellular Biology.
[113] J Wade Harper,et al. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. , 2007, Molecular cell.
[114] Jorma Isola,et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.
[115] Eric S. Lander,et al. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma , 2016, Cell reports.
[116] Neva C. Durand,et al. A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping , 2014, Cell.
[117] S. Philipsen,et al. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. , 1999, Nucleic acids research.
[118] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[119] Jill M Dowen,et al. Control of Cell Identity Genes Occurs in Insulated Neighborhoods in Mammalian Chromosomes , 2014, Cell.
[120] Swneke D. Bailey,et al. ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters , 2015, Nature Communications.
[121] S. Gabriel,et al. Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.
[122] David A. Orlando,et al. Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.
[123] A. Regev,et al. SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.